ZSUZSANNA PREVILLE: Open Payments
NPI 1477882827 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 26 payments from 17 companies in 2025. Trend: 2023 $650 · 2024 $476 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Novo Nordisk Inc | 4 | $61 |
| Lilly USA, LLC | 2 | $40 |
| AngioDynamics, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
Products named: TRELEGY ELLIPTA, Kerendia, Rybelsus, AURYON LASER SYSTEM 100-120 VAC, Ozempic, NEXLETOL, CAPLYTA, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
